CrestecBio Inc.
- Biotech or pharma, therapeutic R&D
CrestecBio is a Japanese start-up company spun out from the University of Tsukuba in 2021. We are developing polymer-based radical scavenging compounds formulated as redox nanoparticles for innovative medical applications.
Our technology enables the creation of polymeric nanomedicines that effectively regulate oxidative stress responses, addressing critical clinical challenges—particularly reperfusion injury in ischemic stroke patients. Based on the favorable pharmacokinetics, efficacy, and safety profile of our lead compound, CTB211, we offer an innovative solution to reduce brain damage and improve neurological outcomes following thrombectomy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}